Efficacy and safety of sunitinib as second-line therapy in patients with metastatic renal cell carcinoma Report uri icon

Overview

MeSH Major

  • Carcinoma, Renal Cell
  • Kidney Neoplasms
  • Vascular Endothelial Growth Factor A

publication date

  • January 2007

Research

keywords

  • Report

Additional Document Info

start page

  • 16

end page

  • 18

volume

  • 6

number

  • 1